Moreover, STAT3’s its abnormal activation together with altered IL-6 levels are often found in chronic inflammatory diseases (Figure 1) as well as in the majority of patients suffering from cancer, making STAT3 and its pathway another attractive target in cancer therapy (57, 62, 63). The gene discussed is STAT3; the disease is cancer.